| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |